Hurdles for Hearing Restoration

Given the diverse cell types and complex structure of the human inner ear, will researchers ever be able to re-create it?

Written byBernd Fritzsch
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

© ONESMALLSQUARE/SHUTTERSTOCK

Hearing loss is as much part of growing old as are cancer and Alzheimer’s, and with the silver tsunami of baby boomers now becoming senior citizens, the impact of age-related hearing loss is becoming increasingly significant. Ongoing research over the last 25 years into gene therapies to correct certain congenital forms of hearing loss appears to be on the verge of a breakthrough, and cell therapies are promising to replace damaged hair cells of the inner ear. (See “Hearing Help.”) But can these achievements be translated to the restoration of age-related hearing loss? As promising and exciting as these data are, researchers still face a monumental challenge in rebuilding aging inner ears. Piecing together such a complex and delicate organ is not as simple as ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies